Loss of adipose tissue or skeletal muscle during first‐line gemcitabine/nab‐paclitaxel therapy is associated with worse survival after second‐line therapy of advanced pancreatic cancer

AIM: Progression of cachexia indicated by decreased body weight and composition is associated with poor survival of advanced pancreatic cancer (APC). There are limited data concerning the prognostic effect of cachexia on second‐line chemotherapy (L2). We aimed to assess the impact of cachexia progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Miki, Masami, Lee, Lingaku, Hisano, Terumasa, Sugimoto, Rie, Furukawa, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541259/
https://www.ncbi.nlm.nih.gov/pubmed/34818466
http://dx.doi.org/10.1111/ajco.13669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541259/
https://www.ncbi.nlm.nih.gov/pubmed/34818466
http://dx.doi.org/10.1111/ajco.13669

Ejemplares similares